Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis

Registration record for the Hong Kong prospective plasma EBV DNA NPC screening program published as Chan et al., NEJM 2017 (PMID 28792880; 20,174 analyzed participants).

Chinese University of Hong Kong